Clinicopathological and Immunohistochemical Characteristics of Esophageal Carcinosarcoma
Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Patients and Methods: Twenty patients with esophageal carcinosarcoma were referred t...
Saved in:
Published in | Anticancer research Vol. 29; no. 8; pp. 3375 - 3380 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Attiki
International Institute of Anticancer Research
01.08.2009
|
Subjects | |
Online Access | Get full text |
ISSN | 0250-7005 1791-7530 1791-7530 |
Cover
Abstract | Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic
factors that influence the clinical outcome of the patient remain a matter of controversy. Patients and Methods: Twenty patients
with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both
carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker.
The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma.
Results: In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle
actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression
of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous
components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell
carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis
than did squamous cell carcinoma patients (p=0.008). Conclusion: The sarcomatous component shows various histological and
immunohisto-chemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis
amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful
for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma. |
---|---|
AbstractList | Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy.BACKGROUNDEsophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy.Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma.PATIENTS AND METHODSTwenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma.In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008).RESULTSIn the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008).The sarcomatous component shows various histological and immunohistochemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma.CONCLUSIONThe sarcomatous component shows various histological and immunohistochemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma. Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma. In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008). The sarcomatous component shows various histological and immunohistochemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma. Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of the patient remain a matter of controversy. Patients and Methods: Twenty patients with esophageal carcinosarcoma were referred to our institutions. Tissue blocks were reviewed and sections containing both carcinomatous and sarcomatous components were stained for epithelial and mesenchymal markers and a proliferating cell marker. The prognosis of the esophageal carcinosarcoma patients was compared with 142 cases of esophageal squamous cell carcinoma. Results: In the carcinomatous component, the expression of cytokeratin, epithelial membrane antigen, vimentin, smooth muscle actin, and S100 were detected in 20, 20, 1, 1, and 1 case, respectively, whereas in the sarcomatous component, expression of these were detected in 4, 2, 18, 15, and 3 cases, respectively. The Ki-67 labeling index of carcinomatous and sarcomatous components was 35.5% and 41.8%, respectively. The 5-year survival rate was not statistically different between squamous cell carcinoma and carcinosarcoma (p=0.219). However, for T1 cases only, carcinosarcoma patients had statistically poorer prognosis than did squamous cell carcinoma patients (p=0.008). Conclusion: The sarcomatous component shows various histological and immunohisto-chemical forms. In comparison with squamous cell carcinoma patients, carcinosarcoma patients had poorer prognosis amongst the T1 cases. For the treatment of esophageal carcinosarcoma, it is important to monitor lymph nodes and be watchful for hematogenous metastasis, as in cases of esophageal squamous cell carcinoma. |
Author | YOSHINORI HOSOYA NARITAKA TANAKA KAZUHA SAKAMOTO HIROYUKI KUWANO MAKOTO SAKAI TAKANORI INOSE AKIHIKO SANO TAKAAKI SANO TETSUNARI OYAMA SHINJI SAKURAI TATSUO KANDA TAKEHIKO ENOMOTO MASANOBU NAKAJIMA HIROYUKI KATO KANA SAITO MAKOTO SOHDA YOICHI AJIOKA |
Author_xml | – sequence: 1 givenname: Akihiko surname: SANO fullname: SANO, Akihiko organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 2 givenname: Shinji surname: SAKURAI fullname: SAKURAI, Shinji organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 3 givenname: Takaaki surname: SANO fullname: SANO, Takaaki organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 4 givenname: Yoshinori surname: HOSOYA fullname: HOSOYA, Yoshinori organization: Department of Surgery, Jichi Medical University, Tochigi 329-0498, Japan – sequence: 5 givenname: Takehiko surname: ENOMOTO fullname: ENOMOTO, Takehiko organization: Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan – sequence: 6 givenname: Tatsuo surname: KANDA fullname: KANDA, Tatsuo organization: Division of Digestive and General Surgery, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan – sequence: 7 givenname: Yoichi surname: AJIOKA fullname: AJIOKA, Yoichi organization: Division of Molecular and Diagnostic Pathology, Niigata University Graduate School of Medical and Dental Sciences, Niigata 951-8510, Japan – sequence: 8 givenname: Tetsunari surname: OYAMA fullname: OYAMA, Tetsunari organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 9 givenname: Hiroyuki surname: KUWANO fullname: KUWANO, Hiroyuki organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 10 givenname: Hiroyuki surname: KATO fullname: KATO, Hiroyuki organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 11 givenname: Makoto surname: SAKAI fullname: SAKAI, Makoto organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 12 givenname: Naritaka surname: TANAKA fullname: TANAKA, Naritaka organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 13 givenname: Takanori surname: INOSE fullname: INOSE, Takanori organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 14 givenname: Kana surname: SAITO fullname: SAITO, Kana organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 15 givenname: Makoto surname: SOHDA fullname: SOHDA, Makoto organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 16 givenname: Masanobu surname: NAKAJIMA fullname: NAKAJIMA, Masanobu organization: Department of General Surgical Science, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan – sequence: 17 givenname: Kazuha surname: SAKAMOTO fullname: SAKAMOTO, Kazuha organization: Department of Diagnostic Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21797630$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19661359$$D View this record in MEDLINE/PubMed |
BookMark | eNpFkctKxDAUhoOMOBd9BelGd4W0aZJ2KWXUAcGNgrtyJk2mkVxq0iK-vVFHXf2H_3yc6xotnHfyBK0K3hQ5pwQv0AqXFOccY7pE6xhfMWasqckZWhYNYwWhzQq9tEY7LfwI0-CNP2gBJgPXZztrZ-cHHScvBmm__XaAAGKSIblaxMyrbBv9OMBBfmUhCO18TOItnKNTBSbKi6Nu0PPt9qm9zx8e73btzUM-lKyZcsalqDimVaX6PREM1ymUBAjBCveVKEmaWnEiSwECSiUoU33fcEZl3dNCkQ26_qk7Bv82yzh1VkchjQEn_Rw7xiljqUECL4_gvLey78agLYSP7vcWCbg6AhDTtiqAEzr-cWW6LGcE_3ODPgzvOsguWjAmlSUdhLLp6o6Q9IFPay141Q |
ContentType | Journal Article |
Copyright | 2009 INIST-CNRS |
Copyright_xml | – notice: 2009 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1791-7530 |
EndPage | 3380 |
ExternalDocumentID | 19661359 21797630 ar29_8_3375 |
Genre | Journal Article |
GroupedDBID | - 23M 53G 55 5GY 5RE 5VS ABFLS ADACO ADBBV ADBIT AENEX ALMA_UNASSIGNED_HOLDINGS BAWUL DIK EBS EJD F5P H13 KQ8 L7B OK1 P2P RHF RHI SJN UDS VRB X7M ZGI --- .55 .GJ AFFNX AIZAD BTFSW IQODW W8F ZXP CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-h269t-67ec470544fdb3c608544e3a330f0d4c23006f73e2caca2fc56fdd9765e8d51f3 |
ISSN | 0250-7005 1791-7530 |
IngestDate | Fri Jul 11 12:34:10 EDT 2025 Thu Apr 03 06:59:47 EDT 2025 Wed Apr 02 07:24:48 EDT 2025 Tue Nov 23 16:34:11 EST 2021 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Immunohistochemistry Esophageal carcinosarcoma Anatomic pathology Cancerology survival analysis Digestive system Malignant tumor Survival Cancer Spindle cell carcinoma Esophagus |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-h269t-67ec470544fdb3c608544e3a330f0d4c23006f73e2caca2fc56fdd9765e8d51f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 19661359 |
PQID | 67566705 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_67566705 pubmed_primary_19661359 pascalfrancis_primary_21797630 highwire_smallpub3_ar29_8_3375 |
PublicationCentury | 2000 |
PublicationDate | 2009-08-01 |
PublicationDateYYYYMMDD | 2009-08-01 |
PublicationDate_xml | – month: 08 year: 2009 text: 2009-08-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Attiki |
PublicationPlace_xml | – name: Attiki – name: Greece |
PublicationTitle | Anticancer research |
PublicationTitleAlternate | Anticancer Res |
PublicationYear | 2009 |
Publisher | International Institute of Anticancer Research |
Publisher_xml | – name: International Institute of Anticancer Research |
SSID | ssj0066983 |
Score | 2.0409255 |
Snippet | Background: Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic
factors that influence the... Esophageal carcinosarcoma is a very rare neoplasm and its clinicopathological characteristics and the prognostic factors that influence the clinical outcome of... |
SourceID | proquest pubmed pascalfrancis highwire |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 3375 |
SubjectTerms | Aged Aged, 80 and over Biological and medical sciences Biomarkers, Tumor - metabolism Carcinoma, Squamous Cell - metabolism Carcinoma, Squamous Cell - mortality Carcinoma, Squamous Cell - pathology Carcinosarcoma - metabolism Carcinosarcoma - mortality Carcinosarcoma - pathology Esophageal Neoplasms - metabolism Esophageal Neoplasms - mortality Esophageal Neoplasms - pathology Female Humans Immunoenzyme Techniques Male Medical sciences Middle Aged Neoplasm Invasiveness Neoplasm Staging Prognosis Survival Rate Tumors |
Title | Clinicopathological and Immunohistochemical Characteristics of Esophageal Carcinosarcoma |
URI | http://ar.iiarjournals.org/content/29/8/3375.abstract https://www.ncbi.nlm.nih.gov/pubmed/19661359 https://www.proquest.com/docview/67566705 |
Volume | 29 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lj5swELaye6h6qfpu9lUOvUVUBBsTjmjVFSzaREoTKT0hxw_1sAurPC79A_3bHWPjhShVHxcSOQY7ntF4vmH8DUKfAixgGxORr0QifDLhxGcqFD5s1utIOxTSJMhOabYkt6toNRj87GQt7Xfrz_zH0XMl_yNVaAO56lOy_yBZ91BogO8gX7iChOH6VzI2pJ61rirsbFiT36sPfdQNlTBvCQGuD5iZdUahLmEA9kT_qksKVfUWPmprqR3Dso52g2psRpYYyAWQ0yLP8mI2-ppOZy5Sk-XT2xyaiuU8dRHZLJ_Pvi2LfFSkC9f1Li1mC313YTu2wYfEpb5ZQNqLWvbSGzqzm3dnZ0wbOF5-HATmfbY0pjdOxj6Ap6Brm200xOjgpGNoMTYFVzpSfnxoxAwmBVwUSzPe49c-2PdcNiLbhEk5KfUjT9AJHjfIPC_aDZ3SxLC5tpNuiGbNIB1aaZ1Vy7YgUGUqovwesjSuy-IlemExh5caBXqFBrJ6jZ7d2ayKN2h1RI880CPviB55B3rk1cp70iOvr0dv0fLmy-I6823FDf97SJOdT2PJSQxePFFijTkFf5wQiRnGgQoE4YBXA6piLEPOOAsVj6gSAjzaSE5ENFb4HTqt6kp-QB5mAQ3HgkiABCThAKwFlzxmIo4BBEdkiK7alSu3D-z-HlYIlx1RQIfeepaPhn6lBBANI-JgiD62C1yCTdQvulgl6_22BBBMKfyNIXpv1t3d28rt7E-jn6PnT_p-gU53m728BPdzt75qlOMXBH6MCg |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinicopathological+and+Immunohistochemical+Characteristics+of+Esophageal+Carcinosarcoma&rft.jtitle=Anticancer+research&rft.au=AKIHIKO+SANO&rft.au=SHINJI+SAKURAI&rft.au=HIROYUKI+KATO&rft.au=MAKOTO+SAKAI&rft.date=2009-08-01&rft.pub=International+Institute+of+Anticancer+Research&rft.issn=0250-7005&rft.eissn=1791-7530&rft.volume=29&rft.issue=8&rft.spage=3375&rft_id=info%3Apmid%2F19661359&rft.externalDBID=n%2Fa&rft.externalDocID=ar29_8_3375 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0250-7005&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0250-7005&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0250-7005&client=summon |